edifoligide
Nucleic acidexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
2
Phase 4
0
Earliest trial started Nov 1, 2001 (NCT00041925)
Timeline
Indications
Mechanism of action
- Transcription factor E2F1INHIBITOR
E2F1 inhibitor
- E2FINHIBITOR
E2F inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2108316 ↗
Also known as
- cgt003
- cgt003
- edifoligide
- edifoligide
- edifoligide
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00086164 | Phase 1/Phase 2 (Phase 2) | May 1, 2004 | Anesiva, Inc. |
| NCT00042081 | Phase 3 | Jul 1, 2002 | Anesiva, Inc. |
| NCT00041925 | Phase 2/Phase 3 (Phase 3) | Nov 1, 2001 | Anesiva, Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Anesiva, Inc. | For profit | 3 | 3 | 2 | 2001 |
1 organizations
Page 1 / 1